Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 27, 2017 Filed Jan 31, 2017 23:27 UTC |
Simmons Jeffrey NSVP&Pres. Elanco Animal Health
|
GrantCommon Stock | 20,551 | $75.38 | $1,549,134.38 |
DisclosureSEC source: 0000059478-17-000049 · wf-form4_148590508158714.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,509 Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 23:29 UTC |
Walsh Fionnuala MSVP, Global Quality
|
GrantRestricted Stock Unit · Derivative | 9,596 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000051 · wf-form4_148590536563577.xml · derivative · entry 5 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,596 Underlying: Common Stock · 9,596 shares Expires 2018-02-01 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 23:29 UTC |
Walsh Fionnuala MSVP, Global Quality
|
GrantCommon Stock | 8,539 | $75.38 | $643,669.82 |
DisclosureSEC source: 0000059478-17-000051 · wf-form4_148590536563577.xml · nonDerivative · entry 3 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 40,190 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 23:29 UTC |
Walsh Fionnuala MSVP, Global Quality
|
GrantCommon Stock | 9,081 | $75.38 | $684,525.78 |
DisclosureSEC source: 0000059478-17-000051 · wf-form4_148590536563577.xml · nonDerivative · entry 1 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,699 Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 23:31 UTC |
Zakrowski Donald AChief Accounting Officer
|
GrantCommon Stock | 2,586 | $75.38 | $194,932.68 |
DisclosureSEC source: 0000059478-17-000053 · wf-form4_148590548503468.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,886 Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 23:34 UTC |
Zulueta Alfonso GSVP& Pres., Emerging Markets
|
GrantRestricted Stock Unit · Derivative | 15,993 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000055 · wf-form4_148590564225593.xml · derivative · entry 3 Zulueta Alfonso G · CIK 0001596336 · SVP& Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,993 Underlying: Common Stock · 15,993 shares Expires 2018-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 23:34 UTC |
Zulueta Alfonso GSVP& Pres., Emerging Markets
|
GrantCommon Stock | 13,150 | $75.38 | $991,247.00 |
DisclosureSEC source: 0000059478-17-000055 · wf-form4_148590564225593.xml · nonDerivative · entry 1 Zulueta Alfonso G · CIK 0001596336 · SVP& Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,051 Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 21:01 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 135 | $73.42 | $9,911.70 |
DisclosureSEC source: 0000059478-17-000002 · wf-form4_148347725166535.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,061 Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 21:05 UTC |
MARRAM ELLEN RDirector
|
GrantCommon Stock | 90 | $73.42 | $6,607.80 |
DisclosureSEC source: 0000059478-17-000004 · wf-form4_148347748801932.xml · nonDerivative · entry 1 MARRAM ELLEN R · CIK 0001234124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,215 Read SEC document |
| December 30, 2016 Filed Feb 23, 2017 23:40 UTC Amendment |
Alvarez RalphDirector
|
GrantCommon Stock | 158 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000106 · wf-form4a_148789319674823.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,084 F1 · shares: This amendment is being filed to correct the number of securities as beneficially owned on the original Form 4. Twenty-three (23) shares were inadvertently omitted from the monthly totals between the period of June through December 2016, and also were omitted from one Form 4 filed by the reporting person after the original Form 4. F1 · balance_after: This amendment is being filed to correct the number of securities as beneficially owned on the original Form 4. Twenty-three (23) shares were inadvertently omitted from the monthly totals between the period of June through December 2016, and also were omitted from one Form 4 filed by the reporting person after the original Form 4. Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 19:15 UTC |
HOOVER R DAVIDDirector
|
PurchaseCommon Stock | 500 | $71.85 | $35,925.00 |
DisclosureSEC source: 0000059478-16-000483 · wf-form4_148217490590987.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Suzanne A. Hoover Revocable Trust Disclosed balance after: 1,500 F1 · ownership.direct: Revocable Trust of which reporting person's spouse is the trustee. Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 19:10 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
SaleCommon Stock | 2,093 | $82.23 | $172,107.39 |
DisclosureSEC source: 0000059478-16-000481 · wf-form4_148217463696571.xml · nonDerivative · entry 1 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,169 Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 19:40 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
SaleCommon Stock | 1,149 | $72.68 | $83,509.32 |
DisclosureSEC source: 0000059478-16-000485 · wf-form4_148217643981276.xml · nonDerivative · entry 3 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 11,479 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 19:40 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
GiftCommon Stock | 737 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000485 · wf-form4_148217643981276.xml · nonDerivative · entry 2 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,065 Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 19:40 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
SaleCommon Stock | 19,093 | $72.65 | $1,387,106.45 |
DisclosureSEC source: 0000059478-16-000485 · wf-form4_148217643981276.xml · nonDerivative · entry 1 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,802 Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 19:45 UTC |
TAI JACKSON PDirector
|
PurchaseCommon Stock | 1,375 | $72.64 | $99,880.00 |
DisclosureSEC source: 0000059478-16-000487 · wf-form4_148217670849918.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,815 Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 19:48 UTC |
Zakrowski Donald AChief Accounting Officer
|
SaleCommon Stock | 1,000 | $72.13 | $72,130.00 |
DisclosureSEC source: 0000059478-16-000489 · wf-form4_148217689282099.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 22:02 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 73,604 | $73.07 | $5,378,023.47 |
DisclosureSEC source: 0001209191-16-155956 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,575,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.83 to $73.35, inclusive. Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 22:02 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 126,396 | $72.32 | $9,140,453.14 |
DisclosureSEC source: 0001209191-16-155956 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,649,408 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.83 to $72.825, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price withing the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| December 16, 2016 Filed Jan 27, 2017 16:37 UTC |
LECHLEITER JOHN CDirector
|
GiftCommon Stock | 375 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000010 · wf-form5_148553501798236.xml · nonDerivative · entry 9 LECHLEITER JOHN C · CIK 0001209281 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 716,869 Read SEC document |
| December 16, 2016 Filed Jan 27, 2017 16:47 UTC |
Rice Derica WEVP-Global Services and CFO
|
GiftCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000012 · wf-form5_148553562181482.xml · nonDerivative · entry 5 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 365,659 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| December 16, 2016 Filed Jan 27, 2017 17:11 UTC |
Ricks David ADirector · President & CEO
|
GiftCommon Stock | 325 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000015 · wf-form5_148553709843634.xml · nonDerivative · entry 2 Ricks David A · CIK 0001538604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,973 Read SEC document |
| December 16, 2016 Filed Jan 27, 2017 17:21 UTC |
Walsh Fionnuala MSVP, Global Quality
|
SaleCommon Stock | 3,000 | $72.23 | $216,690.00 |
DisclosureSEC source: 0000059478-17-000019 · wf-form5_148553764842470.xml · nonDerivative · entry 1 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,618 Read SEC document |
| December 16, 2016 Filed Jan 27, 2017 17:25 UTC |
Zulueta Alfonso GSVP& Pres., Emerging Markets
|
GiftCommon Stock | 1,200 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000021 · wf-form5_148553794289692.xml · nonDerivative · entry 1 Zulueta Alfonso G · CIK 0001596336 · SVP& Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,901 Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 19:29 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,584 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000477 · wf-form4_148096617016804.xml · derivative · entry 6 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 0 Underlying: Common Stock · 4,584 shares Expires 2016-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 19:29 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
Tax withholdingCommon Stock | 1,489 | $67.12 | $99,941.68 |
DisclosureSEC source: 0000059478-16-000477 · wf-form4_148096617016804.xml · nonDerivative · entry 2 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 12,628 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 19:29 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
Exercise / conversionCommon Stock | 4,584 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000477 · wf-form4_148096617016804.xml · nonDerivative · entry 1 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 14,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 21:33 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 2,217 | $76.64 | $169,910.88 |
DisclosureSEC source: 0000059478-16-000460 · wf-form4_148062800739734.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,700 Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 21:35 UTC |
Baicker KatherineDirector
|
GrantCommon Stock | 2,088 | $76.64 | $160,024.32 |
DisclosureSEC source: 0000059478-16-000461 · wf-form4_148062812465813.xml · nonDerivative · entry 1 Baicker Katherine · CIK 0001537067 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,684 Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 21:37 UTC |
ESKEW MICHAEL LDirector
|
GrantCommon Stock | 2,088 | $76.64 | $160,024.32 |
DisclosureSEC source: 0000059478-16-000462 · wf-form4_148062824479883.xml · nonDerivative · entry 1 ESKEW MICHAEL L · CIK 0001227734 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,017 Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 21:39 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 2,088 | $76.64 | $160,024.32 |
DisclosureSEC source: 0000059478-16-000463 · wf-form4_148062835456245.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,439 Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 21:46 UTC |
HOOVER R DAVIDDirector
|
GrantCommon Stock | 2,088 | $76.64 | $160,024.32 |
DisclosureSEC source: 0000059478-16-000465 · wf-form4_148062878562347.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,504 Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 21:48 UTC |
JACKSON JAMEREDirector
|
GrantCommon Stock | 522 | $76.64 | $40,006.08 |
DisclosureSEC source: 0000059478-16-000466 · wf-form4_148062891651896.xml · nonDerivative · entry 1 JACKSON JAMERE · CIK 0001601813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 522 Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 21:50 UTC |
Kaelin William G JrDirector
|
GrantCommon Stock | 2,088 | $76.64 | $160,024.32 |
DisclosureSEC source: 0000059478-16-000467 · wf-form4_148062903286630.xml · nonDerivative · entry 1 Kaelin William G Jr · CIK 0001551715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,246 Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 22:17 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 1,914 | $76.64 | $146,688.96 |
DisclosureSEC source: 0000059478-16-000469 · wf-form4_148063061644614.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,914 Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 22:18 UTC |
MARRAM ELLEN RDirector
|
GrantCommon Stock | 2,174 | $76.64 | $166,615.36 |
DisclosureSEC source: 0000059478-16-000470 · wf-form4_148063070967936.xml · nonDerivative · entry 1 MARRAM ELLEN R · CIK 0001234124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,801 Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 22:21 UTC |
PRENDERGAST FRANKLYN GDirector
|
GrantCommon Stock | 2,088 | $76.64 | $160,024.32 |
DisclosureSEC source: 0000059478-16-000471 · wf-form4_148063089946491.xml · nonDerivative · entry 1 PRENDERGAST FRANKLYN G · CIK 0001233256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,904 Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 22:23 UTC |
Runge Marschall SDirector
|
GrantCommon Stock | 2,088 | $76.64 | $160,024.32 |
DisclosureSEC source: 0000059478-16-000472 · wf-form4_148063102189495.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,187 Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 22:27 UTC |
SEIFERT KATHI PDirector
|
GrantCommon Stock | 2,088 | $76.64 | $160,024.32 |
DisclosureSEC source: 0000059478-16-000474 · wf-form4_148063121873800.xml · nonDerivative · entry 1 SEIFERT KATHI P · CIK 0001222893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,716 Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 22:29 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 2,088 | $76.64 | $160,024.32 |
DisclosureSEC source: 0000059478-16-000475 · wf-form4_148063135656645.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,440 Read SEC document |
| October 31, 2016 Filed Oct 31, 2016 20:19 UTC |
MARRAM ELLEN RDirector
|
GrantCommon Stock | 84 | $78.53 | $6,596.52 |
DisclosureSEC source: 0000059478-16-000442 · wf-form4_147794514723056.xml · nonDerivative · entry 1 MARRAM ELLEN R · CIK 0001234124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,627 Read SEC document |
| October 31, 2016 Filed Oct 31, 2016 20:22 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 126 | $78.53 | $9,894.78 |
DisclosureSEC source: 0000059478-16-000444 · wf-form4_147794534039100.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,483 Read SEC document |
| October 05, 2016 Filed Oct 6, 2016 15:06 UTC |
Crowe Maria APresident, Mfg. Operations
|
SaleCommon Stock | 1,835 | $81.43 | $149,424.05 |
DisclosureSEC source: 0000059478-16-000434 · wf-form4_147576636843231.xml · nonDerivative · entry 2 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,484 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2016. Read SEC document |
| October 04, 2016 Filed Oct 6, 2016 15:06 UTC |
Crowe Maria APresident, Mfg. Operations
|
SaleCommon Stock | 413 | $81.12 | $33,502.56 |
DisclosureSEC source: 0000059478-16-000434 · wf-form4_147576636843231.xml · nonDerivative · entry 1 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,319 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2016. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 18:32 UTC |
Crowe Maria APresident, Mfg. Operations
|
Exercise / conversionRestricted Stock Unit · Derivative | 18,350 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000430 · wf-form4_147560591993472.xml · derivative · entry 6 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,350 shares Expires 2016-10-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 18:32 UTC |
Crowe Maria APresident, Mfg. Operations
|
Tax withholdingCommon Stock | 8,368 | $80.26 | $671,615.68 |
DisclosureSEC source: 0000059478-16-000430 · wf-form4_147560591993472.xml · nonDerivative · entry 4 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,732 Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 18:32 UTC |
Crowe Maria APresident, Mfg. Operations
|
Exercise / conversionCommon Stock | 18,350 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000430 · wf-form4_147560591993472.xml · nonDerivative · entry 3 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2016 Filed Oct 4, 2016 18:27 UTC |
Walsh Fionnuala MSVP, Global Quality
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,760 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000428 · wf-form4_147560563785966.xml · derivative · entry 6 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 0 Underlying: Common Stock · 3,760 shares Expires 2016-10-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| October 02, 2016 Filed Oct 4, 2016 18:27 UTC |
Walsh Fionnuala MSVP, Global Quality
|
Tax withholdingCommon Stock | 1,768 | $80.26 | $141,899.68 |
DisclosureSEC source: 0000059478-16-000428 · wf-form4_147560563785966.xml · nonDerivative · entry 2 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 31,651 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| October 02, 2016 Filed Oct 4, 2016 18:27 UTC |
Walsh Fionnuala MSVP, Global Quality
|
Exercise / conversionCommon Stock | 3,760 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000428 · wf-form4_147560563785966.xml · nonDerivative · entry 1 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 33,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.